Viewray Inc (VRAY) Insider Sells $569,589.51 in Stock

Viewray Inc (NASDAQ:VRAY) insider James F. Dempsey sold 75,243 shares of the company’s stock in a transaction dated Wednesday, March 14th. The stock was sold at an average price of $7.57, for a total transaction of $569,589.51. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Viewray stock opened at $6.35 on Monday. Viewray Inc has a 1-year low of $4.40 and a 1-year high of $10.64. The company has a debt-to-equity ratio of 22.47, a current ratio of 2.18 and a quick ratio of 1.84. The company has a market capitalization of $455.57, a PE ratio of -6.11 and a beta of 0.63.

How to Become a New Pot Stock Millionaire

Viewray (NASDAQ:VRAY) last posted its quarterly earnings results on Monday, March 12th. The company reported ($0.38) earnings per share for the quarter, missing the consensus estimate of ($0.25) by ($0.13). The firm had revenue of $19.90 million for the quarter, compared to analyst estimates of $21.23 million. Viewray’s revenue was up 23.6% on a year-over-year basis. equities analysts forecast that Viewray Inc will post -0.71 earnings per share for the current fiscal year.

Several institutional investors have recently bought and sold shares of the company. Dynamic Technology Lab Private Ltd grew its stake in shares of Viewray by 37.3% in the 3rd quarter. Dynamic Technology Lab Private Ltd now owns 50,281 shares of the company’s stock valued at $290,000 after buying an additional 13,657 shares during the period. Nationwide Fund Advisors grew its stake in shares of Viewray by 843.2% in the 2nd quarter. Nationwide Fund Advisors now owns 16,543 shares of the company’s stock valued at $107,000 after buying an additional 14,789 shares during the period. PEAK6 Investments L.P. purchased a new stake in shares of Viewray in the 4th quarter valued at approximately $148,000. MetLife Investment Advisors LLC acquired a new position in shares of Viewray in the 4th quarter worth approximately $148,000. Finally, Wells Fargo & Company MN lifted its holdings in shares of Viewray by 95.9% in the 3rd quarter. Wells Fargo & Company MN now owns 37,802 shares of the company’s stock worth $218,000 after acquiring an additional 18,502 shares during the last quarter. 80.80% of the stock is owned by institutional investors and hedge funds.

Several analysts recently issued reports on the stock. BidaskClub cut shares of Viewray from a “buy” rating to a “hold” rating in a research note on Wednesday, January 10th. Cantor Fitzgerald set a $13.00 price objective on shares of Viewray and gave the company a “buy” rating in a research note on Monday, January 8th. B. Riley assumed coverage on shares of Viewray in a research note on Thursday, February 8th. They set a “buy” rating and a $13.50 price objective for the company. Finally, Mizuho reaffirmed a “buy” rating and set a $12.00 price objective on shares of Viewray in a research note on Tuesday, January 9th. Two investment analysts have rated the stock with a sell rating and six have given a buy rating to the company’s stock. Viewray currently has a consensus rating of “Buy” and an average price target of $11.58.

WARNING: “Viewray Inc (VRAY) Insider Sells $569,589.51 in Stock” was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this article on another domain, it was illegally stolen and republished in violation of U.S. & international copyright and trademark law. The correct version of this article can be accessed at https://www.dispatchtribunal.com/2018/04/09/viewray-inc-vray-insider-james-f-dempsey-sells-75243-shares.html.

Viewray Company Profile

ViewRay, Inc designs, manufactures and markets MRIdian, the magnetic resonance imaging (MRI)-guided radiation therapy system to image and treat cancer patients simultaneously. The Company offers radiation therapy technology combined with magnetic resonance imaging. MRIdian integrates MRI technology, radiation delivery and the Company’s software to locate, target and track the position and shape of soft-tissue tumors while radiation is delivered.

Insider Buying and Selling by Quarter for Viewray (NASDAQ:VRAY)

Receive News & Ratings for Viewray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viewray and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply